A1110U

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameA1110U
Drug Alias NameBW-1110U81
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRibonucleotide reductase inhibitors
TargetsRibonucleotide reductase
Therapy Area/IndicationsVaricella Zoster Virus InfectionHerpes Simplex
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBurroughs Wellcome
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBurroughs Wellcome
Active IndicationsN/A
Inactive IndicationsVaricella Zoster Virus InfectionHerpes Simplex

Other Information

ATC CodeN/A
Related LinksN/A